GlassScriptPhysician profile
Dashawn L Thomas
NPI 1861843732
$10,853.08
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $815 · 2022: $2,473 · 2023: $1,986 · 2024: $5,579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,202 · Travel and Lodging: $3,033 · Consulting Fee: $1,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,201.94 |
| Travel and Lodging | $3,032.97 |
| Consulting Fee | $1,330.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $5,049.00 | 2022-2024 | Ibsrela |
| Abbvie INC. | $3,774.72 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $398.33 | 2021-2023 | Trulance, Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $309.42 | 2022-2024 | Entyvio, Eohilia |
| E.R. Squibb & Sons, L.L.C. | $238.81 | 2022-2023 | Zeposia |
| Ferring Pharmaceuticals INC. | $180.48 | 2022-2023 | Rebyota |
| Janssen Scientific Affairs, LLC | $144.20 | 2022 | |
| Lilly USA, LLC | $121.87 | 2024 | Omvoh |
| Janssen Biotech, INC. | $110.55 | 2021-2022 | |
| Redhill Biopharma INC. | $108.58 | 2021 | |
| Pfizer INC. | $106.86 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $83.79 | 2021 | |
| Genzyme Corporation | $50.37 | 2022-2023 | |
| Braintree Laboratories, INC. | $34.92 | 2022-2023 | Sutab |
| Qol Medical, LLC | $31.18 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $29.49 | 2022 | |
| Pharmacosmos Therapeutics INC. | $28.60 | 2023 | Monoferric |
| Celltrion USA INC. | $18.51 | 2024 | Vegzelma |
| Blueprint Medicines Corporation | $17.78 | 2022 | |
| Nestle Healthcare Nutrition INC. | $15.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dashawn Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.